CARL Carlsmed, Inc.

17.22USD-0.86%Mkt Cap: 471.90M USDP/E: —

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spin…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap471.90M USD
Enterprise Value417.59M USD
Revenue (TTM)71.78M USD
Gross Profit38.04M USD
Net Income (TTM)-29.63M USD
Revenue/Share2.66 USD
Last Price17.22 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees127
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-11.04
PEG—
EV/EBITDA-9.97
EV/Revenue5.82
P/S6.57
P/B6.23
EPS (TTM)-1.15 USD
EPS (Forward)-1.56 USD
52W Range
8.50082% of range19.15
52W High19.15 USD
52W Low8.500 USD
Profitability
Gross Margin75.31%
Oper. Margin-58.98%
EBITDA Margin-58.35%
Profit Margin-58.67%
ROE-29.97%
ROA-22.77%
ROIC-372.16%
ROCE-26.39%
Growth
Revenue Growth64.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-28.98M USD
CapEx (TTM)1.36M USD
FCF Margin-31.62%
FCF Yield-4.81%
Net Debt-58.42M USD
Net Debt/EBITDA1.40
Net Debt/FCF—
Balance Sheet
Debt/Equity0.18
Current Ratio5.79
Quick Ratio5.32
Book Value/Sh2.76 USD
Cash/Share2.93 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)22.00 USD
Upside (mean)+27.8%
Target Range18.00 USD – 26.00 USD
18.00+27.8% to mean26.00
# Analysts5
Ownership
Shares Out.27.40M
Float15.75M
Insiders43.27%
Institutions44.02%
Short Interest
Short Ratio15.1d
Short % Float12.04%
Short % Out.4.53%
Shares Short1.24M
Short (prev mo.)1.05M
Technical
SMA 5015.00 (+14.8%)
SMA 20012.57 (+37.0%)
Beta—
S&P 52W Chg12.08%
Avg Vol (30d)130.03K
Avg Vol (10d)209.04K
Technical Indicators
RSI (14)57.0
MACD0.7407
MACD Signal0.5684
MACD Hist.+0.1723
BB Upper18.54 USD
BB Middle15.98 USD
BB Lower13.43 USD
BB Width32.00%
ATR (14)1.264 USD
Vol Ratio (20d)0.59x

About Carlsmed (NASDAQ: CARL)

›

Carlsmed (NASDAQ: CARL) is listed on Nasdaq, where its shares trade in USD. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 127 employees.

The shares were at 17.22 USD on 19 November 2026, up 40.6% over 52 weeks. Its 52-week range is 8.500 USD to 19.15 USD: the price is 10.1% below the high and 102.6% above the low.

Its market capitalisation is 471.90M USD.

Carlsmed reports return on equity of -30.0%, an operating margin of -59.0% and revenue up 64.9% year over year.

It holds more cash than debt, a net cash position of 58.42M USD. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 5 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 22.00 USD is 27.8% above the current price. The next earnings report is expected on 25 February 2027.